Mora Marirosa, Donati Claudio, Medini Duccio, Covacci Antonello, Rappuoli Rino
Novartis Vaccines, Via Fiorentina, 53100 Siena, Italy.
Curr Opin Microbiol. 2006 Oct;9(5):532-6. doi: 10.1016/j.mib.2006.07.003. Epub 2006 Aug 4.
The advent of whole-genome sequencing of bacteria and advances in bioinformatics have revolutionized the study of bacterial pathogenesis, enabling the targeting of possible vaccine candidates starting from genomic information. Nowadays, the availability of hundreds of bacterial genomes enables identification of the genetic differences across several genomes from the same species. The unexpected degree of intra-species diversity suggests that a single genome sequence is not entirely representative and does not offer a complete picture of the genetic variability of a species. The practical consequence is that, in many cases, a universal vaccine is possible only by including a combination of antigens and this combination must take into account the pathogen population structure.
细菌全基因组测序的出现以及生物信息学的进展彻底改变了细菌致病机制的研究,使得从基因组信息出发确定可能的疫苗候选物成为可能。如今,数百种细菌基因组的可得性使得我们能够识别同一物种中多个基因组之间的遗传差异。种内多样性的意外程度表明,单一基因组序列并不完全具有代表性,无法全面呈现一个物种的遗传变异性。实际的结果是,在许多情况下,只有通过包含多种抗原的组合才能研发出通用疫苗,而且这种组合必须考虑病原体的群体结构。